Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michel Chauvin is active.

Publication


Featured researches published by Michel Chauvin.


The New England Journal of Medicine | 2008

Sudden Cardiac Arrest Associated with Early Repolarization

Michel Haïssaguerre; Nicolas Derval; Frederic Sacher; Laurence Jesel; Isabel Deisenhofer; Luc De Roy; Jean-Luc Pasquié; Akihiko Nogami; Dominique Babuty; Sinikka Yli-Mayry; Christian de Chillou; Patrice Scanu; Philippe Mabo; Seiichiro Matsuo; Vincent Probst; Solena Le Scouarnec; Pascal Defaye; Juerg Schlaepfer; Thomas Rostock; Dominique Lacroix; Dominique Lamaison; Thomas Lavergne; Yoshifusa Aizawa; Anders Englund; Frederic Anselme; Mark O'Neill; Mélèze Hocini; Kang-Teng Lim; Sébastien Knecht; George D. Veenhuyzen

BACKGROUND Early repolarization is a common electrocardiographic finding that is generally considered to be benign. Its potential to cause cardiac arrhythmias has been hypothesized from experimental studies, but it is not known whether there is a clinical association with sudden cardiac arrest. METHODS We reviewed data from 206 case subjects at 22 centers who were resuscitated after cardiac arrest due to idiopathic ventricular fibrillation and assessed the prevalence of electrocardiographic early repolarization. The latter was defined as an elevation of the QRS-ST junction of at least 0.1 mV from baseline in the inferior or lateral lead, manifested as QRS slurring or notching. The control group comprised 412 subjects without heart disease who were matched for age, sex, race, and level of physical activity. Follow-up data that included the results of monitoring with an implantable defibrillator were obtained for all case subjects. RESULTS Early repolarization was more frequent in case subjects with idiopathic ventricular fibrillation than in control subjects (31% vs. 5%, P<0.001). Among case subjects, those with early repolarization were more likely to be male and to have a history of syncope or sudden cardiac arrest during sleep than those without early repolarization. In eight subjects, the origin of ectopy that initiated ventricular arrhythmias was mapped to sites concordant with the localization of repolarization abnormalities. During a mean (+/-SD) follow-up of 61+/-50 months, defibrillator monitoring showed a higher incidence of recurrent ventricular fibrillation in case subjects with a repolarization abnormality than in those without such an abnormality (hazard ratio, 2.1; 95% confidence interval, 1.2 to 3.5; P=0.008). CONCLUSIONS Among patients with a history of idiopathic ventricular fibrillation, there is an increased prevalence of early repolarization.


Circulation | 2000

Electrophysiological Breakthroughs From the Left Atrium to the Pulmonary Veins

Michel Haïssaguerre; Dipen Shah; Pierre Jaïs; Mélèze Hocini; Teiichi Yamane; Isabel Deisenhofer; Michel Chauvin; Stéphane Garrigue; Jacques Clémenty

Background—The extent of ostial ablation necessary to electrically disconnect the pulmonary vein (PV) myocardial extensions that initiate atrial fibrillation from the left atrium has not been determined. Methods and Results—Seventy patients underwent PV mapping with a circumferential 10-electrode catheter during sinus rhythm or left atrial pacing. After assessment of perimetric distribution and activation sequence of PV potentials, ostial ablation was performed at segments showing earliest activation, with the end point of PV disconnection. A total of 162 PVs (excluding right inferior PVs) were ablated. PV potentials were present at 60% to 88% of their perimeter, but PV muscle activation was always sequential from a segment with earliest activation (breakthrough). Radiofrequency (RF) application at this breakthrough eliminated all PV potentials in 34 PVs, whereas a secondary breakthrough required RF applications at separate segments in 77; in others, >2 segments were ablated. A median of 5, 6, and 4 bipoles from the circular catheter were targeted in the right superior, left superior, and inferior PVs, respectively, to achieve PV disconnection. Early recurrence of arrhythmia was observed in 31 patients as a result of new venous or atrial foci or recovery of previously targeted PVs, most related to a single recovered breakthrough that was reablated with local RF application. Conclusions—Although PV muscle covers a large extent of the PV perimeter, there are specific breakthroughs from the left atrium that allow ostial PV disconnection by use of partial perimetric ablation.


Circulation | 2000

The Anatomic Basis of Connections Between the Coronary Sinus Musculature and the Left Atrium in Humans

Michel Chauvin; Dipen Shah; Michel Haïssaguerre; Luc Marcellin; Claude Brechenmacher

BACKGROUND This study determined the histological features of the atrial myocardium connecting the coronary sinus and the left atrium in humans. METHODS AND RESULTS Ten necropsied hearts were studied by performing serial longitudinal sections parallel to the long axis of the coronary sinus that extended its full length using a large microtome. In all specimens, the venous wall of the coronary sinus was surrounded by a cuff of striated muscle extending 40+/-8 mm from the ostium. Striated myocardial connections of varying number and morphology left this coronary muscle cuff and connected to the left atrium; they ranged from 1 to 2 fascicles to a widely intermingled continuum (thickness, 2.79+/-2 mm; width, 2.91+/-3.5 mm). These connections originated 8.8+/-5.7 mm from the coronary sinus ostium and inserted 18+/-11 mm distally into the left atrium. The insulating compartment in which the connections traversed between the left atrium and the coronary sinus was mostly formed of adipose tissue. The valve of Vieussens was found in 6 hearts at a mean distance of 3.4+/-3.2 mm from the distal extremity of the coronary sinus muscle cuff. CONCLUSIONS In the human heart, a consistent but morphologically variable left atrial coronary sinus myocardial connection was found. This emphasizes the need for surgical dissection or catheter ablation in or around the coronary sinus to eliminate these connections.


Pacing and Clinical Electrophysiology | 2005

Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients

Laurent Fauchier; Nicolas Sadoul; Claude Kouakam; Florent Briand; Michel Chauvin; Dominique Babuty; Jacques Clémenty

Home monitoring (HM) of cardioverter defibrillators (ICD) with its automated wireless remote data access, may decrease the rate of patient visits. This study examined the potential cost savings for the long‐term care of ICD assisted by HM. A French database including 502 patients from 6 university hospitals was used. Costs of conventional follow‐up (FU) of ICD were calculated without, and compared with the expected cost of FU with HM. Calculations included number of visits, including physicians fees, electrocardiograms, and specific ICD surveillance, and transportation costs. The mean distance between home and institutions performing follow‐ups was 69 ± 57 km. For each visit, a mean overall cost of


Pacing and Clinical Electrophysiology | 1997

Preliminary clinical experience with the first dual chamber pacemaker defibrillator.

Thomas Lavergne; Jean-Claude Daubert; Michel Chauvin; Eric Dolla; Salem Kacet; Antoine Leenhardt; Philippe Mabo; Philippe Ritter; Nicolas Sadoul; Nadir Saoudi; Christine Henry; Remi Nitzsche; Alain Ripart; Francis Murgatroyd

215 was calculated, including


Thrombosis and Haemostasis | 2004

Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus.

Olivier Morel; Bénédicte Hugel; Laurence Jesel; François Lanza; Marie-Pierre Douchet; Michel Zupan; Michel Chauvin; Jean-Pierre Cazenave; Jean-Marie Freyssinet; Florence Toti

121 for transportation and


European Heart Journal | 2015

Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study

Eloi Marijon; Christophe Leclercq; Kumar Narayanan; Serge Boveda; Didier Klug; Jonathan Lacaze-Gadonneix; Pascal Defaye; Sophie Jacob; Olivier Piot; Jean-Claude Deharo; Marie-Cécile Perier; Genevieve Mulak; Jean-Sylvain Hermida; Paul Milliez; Daniel Gras; Olivier Cesari; Françoise Hidden-Lucet; Frederic Anselme; Philippe Chevalier; Philippe Maury; N. Sadoul; Pierre Bordachar; Serge Cazeau; Michel Chauvin; Jean-Philippe Empana; Xavier Jouven; Jean-Claude Daubert; Jean-Yves Le Heuzey

94 for medical services. HM may obviate up to 2 visits per year. Over the 5 years of expected life of the device, the decrease in costs for FU visits was estimated at


Jacc-cardiovascular Interventions | 2010

Impact of P2Y12 Inhibition by Clopidogrel on Cardiovascular Mortality in Unselected Patients Treated by Percutaneous Coronary Angioplasty: A Prospective Registry

Soraya El Ghannudi; Patrick Ohlmann; Nicolas Meyer; Marie-Louise Wiesel; Bogdan Radulescu; Michel Chauvin; Pierre Bareiss; Christian Gachet; Olivier Morel

2,149. With an additional cost of


Journal of Cardiovascular Electrophysiology | 2004

Death Due to an Implantable Cardioverter Defibrillator

A. Messali; Olivier Thomas; Michel Chauvin; Philippe Coumel; Antoine Leenhardt

1,200 for the HM system, saving began after a mean FU of 33.5 months. The time to onset of cost saving by HM ranged between 17.4 months for patients living >150 km from the medical facility to 52.2 months for those living <50 km away. It is concluded that the HM may considerably reduce the overall costs of ICD FU by saving on transportation cost, particularly when the distance between home and medical facility is >100 km.


Pacing and Clinical Electrophysiology | 1997

THE VALUE OF DDD PACING IN PATIENTS WITH AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

Peter Geelen; Adalberto Lorga F; Michel Chauvin; Francis Wellens; Pedro Brugada

The lack of specificity of VT detection is a significant shortcoming of current ICDs. In a French multicenter study, 18 patients underwent implantation of the Defender 9001 (ELA Medical), an ICD utilizing dual chamber pacing and arrhythmia detection. Over a mean follow‐up period of 7.1 ± 4.5 months, 176 tachycardia episodes recorded in the device memory were analyzed, and physician diagnosis was compared with that by the device. All 122 VT/VF episodes were correctly diagnosed, as were 51 of 53 supraventricular tachyarrhythmias. Two episodes of AF with rapid regular ventricular rates were treated as VT, and a third episode, treated as VT, could not be diagnosed with certainty. A dual chamber pacemaker defibrillator offers improved diagnostic specificity without loss of sensitivity, in addition to the hemodynamic benefit of dual chamber pacing. (PACE 1997;20

Collaboration


Dive into the Michel Chauvin's collaboration.

Top Co-Authors

Avatar

Laurence Jesel

University of Strasbourg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Didier Klug

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar

Gerald Roul

University of Strasbourg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Halim Marzak

University of Strasbourg

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge